AGX ARGAN INC Insider Trading

William F Jr Griffin (Director) sold 50,000 shares of AGX for $36,984,100.00 across two transactions

William F Jr Griffin sold 50,000 shares (50.0K shares) for $36,984,100.00 ($37.0M) at a blended average price of $739.68, reducing his stake by 55.0% from 91.0K to 41.0K shares. The sales occurred as AGX trades near its 52-week high of $791.38 (current price $736.77 is -6.9% below peak), and follow a 12.2% 30-day and 68.4% 90-day price appreciation. Across his prior trades at this ticker, his same-ticker history shows 1 of 5 prior sells were well-timed at the 90-day mark, with outcomes ranging from -2.6% to +70.1% over 90 days; the most recent prior sale on 2024-10-30 returned +14.6% in 30 days and +1.3% in 90 days. This substantial single-filer liquidation of over half a director's holdings warrants investor attention to whether it reflects evolving conviction in the company or capital reallocation, though the company's fundamentals show $291.0M in latest quarterly revenue with $46.1M net income and 8.1% annual growth.

CFO Joshua Scott Baugher sells 760 shares at avg $733.30; retains 1,479 shares plus 1,708 option holdings

Joshua Scott Baugher, CFO of Argan Inc, executed 2 separate sales totaling 760 shares for $557,307.65 at blended average price $733.30 on 2026-06-17. His non-derivative holdings declined from 2,239 shares to 1,479 shares (a -33.9% reduction), but he retains 1,708 shares through derivative option holdings, preserving meaningful equity exposure. The stock currently trades at $719.52, down -7.6% from its 52-week high of $779.00, while the 90-day performance shows +49.9% appreciation. At a P/E of 62.57 and market cap of $10.1B against recent quarterly net income of $46.1M, the company's valuation reflects significant premium positioning; the partial reduction in direct share count occurs in this elevated price context.

Peter W Getsinger (Director, AGX) sold 6,728 shares for $4,748,497.20 across 2 transactions; retains 4,880 shares + 3,000 option units

Director Peter W Getsinger executed 2 separate sales totaling 6,728 shares for $4,748,497.20 on June 16–17, 2026, at prices of $708.65 and $699.00, reducing his non-derivative holdings by -58.0% from 11,608 to 4,880 shares. The stock is trading at $719.52, up +8.2% over 30 days and +49.9% over 90 days, while trading -7.6% from its 52-week high of $779.00. Looking at his prior 5 trades at AGX, none of the 3 measurable 90-day outcomes were well-timed (all showed positive 90-day returns), suggesting his sales have historically not preceded declines at this ticker. The company's fundamentals show revenue of $290,954,000.00 and net income of $46,063,000.00 in the latest quarter, with a P/E of 62.57 and market cap of $10,087,128,601.44. Getsinger retains derivative holdings of 3,000 shares via options, meaning his overall position is not fully exited.

Director Cynthia Flanders sold 2,596 shares of AGX at $666.31 for $1,729,740.76 on 2026-06-15.

Cynthia Flanders, a director at Argan Inc, sold 2,596 shares at $666.31, reducing her holdings from 25,740 to 23,144 shares. The sale occurred when AGX is trading at $690.39, some 11.4% below its 52-week high of $779.00 and down 4.4% over the past 30 days despite a strong 47.0% gain over 90 days. Reviewing her prior trades specifically at AGX, of 5 previous transactions across 2023–2026, only 1 proved well-timed at the 90-day mark, suggesting inconsistent execution in timing sales at this ticker. Her cross-ticker track record shows a 0.00% well-timed rate on 4 prior sells, indicating that past sales have tended to be followed by price appreciation rather than declines. This latest transaction does not offer a clear directional signal about her conviction given the mixed historical outcomes at this specific ticker.

Director William F Jr Griffin sells 50,000 AGX shares at $643.46, totaling $32.2M, reducing holdings by -35.5%

William F Jr Griffin, a Director at Argan Inc, sold 50,000 shares at $643.46 on 2026-06-12 for a total value of $32,173,000.00, reducing his position by -35.5% from 140,976 shares to 90,976 shares post-transaction. The sale occurred with AGX currently trading at $690.39, which is -11.4% from its 52-week high, and after a strong 90-day run of +47.0%. His cross-ticker track record shows a 90d well-timed rate of only 20.00% across 5 prior sells, meaning the stock has generally risen after his past sales — the average 90d return following his cross-ticker sells is +52.0%. His 5 prior trades at AGX tell a similar story: only 1 of those 5 prior sells was well-timed at the 90-day mark, with notable post-sale gains such as +67.0% and +70.1% at 90 days following July 2024 sales.

AGX CEO David Hibbert Watson sells 11,873 shares for $7,837,459.46 across 2 transactions at blended $660.11 avg

David Hibbert Watson, President and CEO of ARGAN INC, executed 2 separate sales totaling 11,873 shares for $7,837,459.46, reducing his non-derivative holdings from 51,878 to 40,005 shares. The stock currently trades at $690.39, near the 52-week high of $779.00, suggesting the CEO sold into strength; however, his cross-ticker track record shows a well-timed rate of 33.33% on prior sells, indicating mixed timing performance overall. At AGX specifically, his prior 4 measurable sales showed only 1 well-timed at the 90-day mark, with 3 sales subsequently rising (poorly timed). Despite the substantial share reduction, derivative holdings of 10,578 shares remain across 3 option pools, meaning this represents a partial reduction rather than a complete position exit.

Director Peter W Getsinger sells 3,000 AGX shares at $628.36; stock now at $669.98 (+0.0% from 52-week high)

Getsinger sold 3,000 shares (representing -32.1% of his pre-transaction holdings of 9,347 shares) for $1.9M on 2026-04-29, leaving him with 6,347 shares. The sale occurred near the stock's 52-week high of $669.98, with current price at $669.98 (+0.0% from that peak). His prior trades at AGX show a consistent pattern: 4 measurable prior sales all resulted in positive 90-day returns (ranging from +12.9% to +87.5%), meaning he has sold before rallies rather than declines—a 0% well-timed rate at this ticker. His cross-ticker history across 7 prior sales shows a 33.33% well-timed rate with an average 90-day return of +30.8%, indicating modest accuracy in timing exits across his broader trading. With AGX trading at a P/E of 54.25 and the recent 30-day and 90-day price changes of +23.0% and +93.0% respectively, the stock has appreciated significantly since this transaction—consistent with his historical pattern of selling into strength.

Director Jeffrey John Ronald Jr. sells majority of AGX stake in near-record-high market, timing raises questions on conviction.

Jeffrey John Ronald Jr., a member of Argan's board, liquidated more than half his holdings in a single transaction as the stock traded near its yearly peak and following a sharp recovery period. The director's sale of over $1.7 million in shares is substantial and points toward a reduction in his personal conviction at this valuation level—particularly notable because the sale comes after the stock has rebounded sharply. While Argan remains fundamentally healthy with steady revenue growth and strong profitability, the timing suggests Ronald may view current prices as attractive for diversifying his personal wealth rather than a vote of confidence in future upside. The sale itself is not alarming in isolation, but paired with the stock's stretched valuation relative to its recent momentum, it warrants attention as a potential signal that insiders are taking chips off the table.

Director Leimkuhler sold 5,800 shares of AGX for $3,582,950.00 (-92.1% of holdings) at $617.75 blended avg

Director William F. Leimkuhler executed 3 separate sales totaling 5,800 shares for $3,582,950.00 on 2026-04-28, reducing his stake from 6,300 to 500 shares. This represents a -92.1% reduction in his holdings in Argan Inc at a blended average price of $617.75, just 6.7% below the current price of $630.07. While the aggregate sale is material in absolute dollar terms, the company shows solid fundamentals with revenue of $251,153,000.00 and net income of $30,737,000.00 in the latest quarter, alongside 8.1% annual growth. At a P/E of 51.02, the valuation appears elevated; Leimkuhler's prior 5 trades at AGX have shown poor sell timing, with 0 of 4 prior sells well-timed at the 90-day horizon (all 90-day returns positive, ranging from 14.8% to 89.7%), suggesting he has historically exited before subsequent gains.

Director Jeffrey John Ronald Jr. sold 3,636 shares of AGX at $615.40, reducing holdings by 43.6%; stock now at $651.68.

Director Jeffrey John Ronald Jr. sold 3,636 shares of ARGAN INC at $615.40 on 2026-04-21, reducing his holdings from 8,334 to 4,698 shares—a 43.6% reduction in position. The stock has since moved to $651.68, reflecting a +5.9% move above the sale price. Across his prior trades at AGX, only 1 of 3 measurable sales at the 90-day mark resulted in subsequent stock declines (33% well-timed rate), and his most recent same-ticker sale on 2026-03-31 remains outcome-indeterminate. The company shows solid fundamentals with $251.2M quarterly revenue, $30.7M net income, and 8.1% annual revenue growth, though the stock trades at a high 52.77 P/E ratio and recently surged +40.7% over 30 days and +71.3% over 90 days—levels at which a substantial director reduction warrants observer attention for whether it signals reduced conviction at current valuations.